Shoulder Arthritis

9

Review clinical trials related to Shoulder Arthritis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain

To prospectively describe patient-centered and health utilization outcomes through 12 months after cryoneurolysis performed as routine clinical care for chronic pain at Yale.

Participants needed: 80
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Yale UniversityUpdated: Jun 10, 2026
Eligibility criteria

Diagnosis of chronic pain (generally pain duration of at least 3-6 months) local... [+3]

Cryoneurolysis performed as part of a separate investigational trial in which da... [+3]

Status: Not yet recruiting

A Study Comparing Shoulder Replacement Techniques For Patients With Shoulder Arthritis And An Intact Rotator Cuff

The purpose of this study is to determine if patients undergoing anatomic total shoulder arthroplasty (aTSA) will have improved patient reported outcome scores at 1 year compared to those undergoing reverse total shoulder arthroplasty (rTSA).

Participants needed: 108
Trial details
Age: 60-85Biological sex: AllType: InterventionalSponsor: Mayo ClinicUpdated: May 13, 2026Locations: 1
Eligibility criteria

Shoulder arthritis [+2]

Rotator cuff insufficiency [+10]

Status: Not yet recruiting

OsseoFit Stemless Shoulder System (Anatomic)

The purpose of this clinical research protocol is to evaluate the safety, efficacy, and long-term outcomes of the OsseoFit Stemless Shoulder System (Anatomic) in patients with a primary diagnosis of osteoarthritis. The study aims to assess the intraoperative characteristics, postoperative complications, functional outcomes, and radiographic findings associated with the use of the stemless implant system. Ultimately, this research aims to improve patient outcomes, enhance surgical techniques, and inform clinical decision-making in the treatment of shoulder pathology.

Participants needed: 136
Trial details
Age: 20+Biological sex: AllType: ObservationalSponsor: Zimmer BiometUpdated: Apr 23, 2026Locations: 1
Eligibility criteria

Patient must be 20 years of age or older. [+6]

Patient is unwilling or unable to give consent or to comply with the follow-up p... [+17]

Status: Recruiting

MDR - Comprehensive Primary Revision Stems PMCF

The objective of this retrospective and prospective consecutive series PMCF (Post Market Clinical Follow Up) study is to collect long-term data confirming safety, performance and clinical benefits of the Comprehensive Primary Revision Stems (implants and instrumentation) when used for shoulder arthroplasty at 1, 3, 5, 7 and 10 years.

Participants needed: 59
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Zimmer BiometUpdated: Apr 28, 2026Locations: 2
Eligibility criteria

Patient must be 18 years of age or older. [+2]

Off-label use. [+5]

Status: Recruiting

Zimmer Biomet Shoulder Arthroplasty PMCF

The objectives of this study are to confirm the safety, performance, and clinical benefits of Zimmer Biomet Shoulder Arthroplasty Systems and its instrumentation in primary or revision shoulder arthroplasty. These objectives will be assessed using standard scoring systems, radiographic evidence, and adverse event records. Safety of the system will be assessed by monitoring the frequency an incidence of adverse events.

Participants needed: 584
Trial details
Age: 20+Biological sex: AllType: InterventionalSponsor: Zimmer BiometUpdated: Apr 28, 2026Locations: 17
Eligibility criteria

Patient must be 20 years of age or older. [+12]

Patient is unwilling or unable to give consent or to comply with the follow-up p... [+14]

Status: Recruiting

Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block

This prospective observational study aims to evaluate the incidence of hemidiaphragmatic paralysis in patients receiving interscalene brachial plexus nerve block with prolonged neural blockade. English speaking American Society of Anesthesiologists (ASA) 1-3 patients ages 18-80 receiving prolonged interscalene nerve block will be randomized into 3 groups: first group receiving a perineural catheter infusing 0.2% ropivacaine; the second group receiving a single shot injection of 10mL liposomal bupivacaine (Exparel; n=20) plus 5 mL 0.5% bupivacaine and the third receiving 20mL liposomal bupivacaine plus 5mL bupivacaine (to be determined by the attending anesthesiologist).Primary outcome will be incidence of hemidiaphragmatic paralysis postoperative day 1 as measured by point of care (POCUS) ultrasound.

Participants needed: 60
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Duke UniversityUpdated: Oct 1, 2025Locations: 1
Eligibility criteria

English speaking 18-80 year old ASA 1-3 patients [+2]

ASA 4 or 5 [+14]

Status: Recruiting

Study of Personalized Instrument in Total Shoulder Arthroplasty The P.I.T.S.A. Study

Total shoulder arthroplasty is an effective procedure to improve patients function and to relieve shoulder pain in cases of glenohumeral arthritis. The main challenge of this procedure is implanting the glenoid component. Indeed, surgical exposure is difficult and proper visualization of the glenoid is demanding. The current free-hand method is not precise and especially unreliable in glenoids with severe deformity. Inappropriate reaming and glenoid positioning can cause more bone loss during surgery. In anatomic prostheses, glenoid component fixation is demanding and is the first component to present loosening at long term follow-up. When it comes to reverse arthroplasty, the glenoid component, once again, requires the most attention. Malpositioning of the glenosphere can cause notching, loosening, and instability. In order to prevent these complications, precision in glenoid implantation is key. To this end, intraoperative computer navigation would be a helpful tool, but the increased expenses in computer equipment represent massive costs and possibly increases in surgical time. A more affordable option is a personalized guide, for which the only extra expense is the customized guide. These guides are based on precise 3D CT scan templates. Previous studies have evaluated the precision of the guide in vivo and in vitro, but none have measured it in a randomized study. As it represents additional costs, its efficacy needs to be proven before widespread use. This method may also provide secondary benefits, such as decreasing operating time, lowering short- and long-term complications, and improving efficacy. The objective of this study is to evaluate the performance of a patient specific glenoid guide.

Participants needed: 112
Trial details
Age: 18-99Biological sex: AllType: InterventionalSponsor: Université de MontréalUpdated: Sep 22, 2025Locations: 1
Eligibility criteria

Patients with shoulder osteaoarthritis and AVN

Patients with previous shoulder arthroplasty [+6]

Status: Recruiting

AETOS Shoulder System

The goal of this study is to confirm the safety and performance of the AETOS Shoulder System for USA adoption. This is a prospective, open, adaptive, non-comparative, multi-centre investigation enrolling a maximum of 220 subjects in 2 cohorts (anatomic and reverse) at up to 15 sites. No intra-study comparator group will be included, and there will be no randomization

Participants needed: 220
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Smith & Nephew, Inc.Updated: May 7, 2024Locations: 5
Eligibility criteria

Patient is at least 18 years of age at the time of consent and skeletally mature... [+7]

Patient has a contraindication to AETOS. [+23]

Status: Not yet recruiting

S-11 SMR TT Hybrid Glenoid and Cementless Finned Short Stem

Post-market, prospective, non randomized, open label, multicentre, clinical study analysing outcomes of shoulder arthroplasty with SMR TT Hybrid Glenoid with or without SMR Cementless Finned Short Stem

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Limacorporate S.p.aUpdated: Apr 6, 2022
Eligibility criteria

Both genders; [+13]

Patient requiring revision shoulder arthroplasty; [+10]